"I’m driven by the impact applied organic chemistry can have on addressing broad therapeutic challenges"
I joined the Discovery Chemistry (medicinal chemistry) group at Genentech in 2007 after completing my PhD in organic chemistry at UC Berkeley. My current role includes leading interdisciplinary teams directed toward the common goal of delivering novel therapeutics that can impact patient’s lives.
One of the great things about Genentech is a strong investment in basic scientific research that includes a postdoctoral program. Combine that with great infrastructure, support-teams and resources, and I think we are uniquely positioned to tackle challenging scientific questions. I really enjoy the opportunity to work together with my colleagues to answer basic scientific curiosities that we share.
J. Med. Chem. 2013; 56, 4597-4610
As a medicinal chemist, I use my knowledge of physical properties, reactivity, molecular conformation and interaction energies to design inhibitors of a variety of therapeutic targets. My basic research interests include: new target validation, novel strategies for inhibitor design, and methodologies useful for rapid/divergent heterobiaryl synthesis.